Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 18 studies | 35% ± 17% | |
macrophage | 16 studies | 28% ± 14% | |
conventional dendritic cell | 15 studies | 35% ± 10% | |
plasmacytoid dendritic cell | 12 studies | 36% ± 17% | |
mast cell | 11 studies | 32% ± 18% | |
smooth muscle cell | 7 studies | 24% ± 3% | |
monocyte | 6 studies | 31% ± 11% | |
myeloid cell | 6 studies | 35% ± 10% | |
fibroblast | 6 studies | 25% ± 9% | |
pericyte | 6 studies | 35% ± 14% | |
B cell | 5 studies | 17% ± 1% | |
classical monocyte | 5 studies | 24% ± 2% | |
non-classical monocyte | 4 studies | 18% ± 1% | |
mononuclear phagocyte | 4 studies | 30% ± 10% | |
mucosal invariant T cell | 3 studies | 21% ± 1% | |
T cell | 3 studies | 33% ± 24% | |
gamma-delta T cell | 3 studies | 26% ± 2% | |
innate lymphoid cell | 3 studies | 18% ± 2% | |
monocyte-derived dendritic cell | 3 studies | 33% ± 6% | |
muscle cell | 3 studies | 24% ± 4% | |
leukocyte | 3 studies | 25% ± 4% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 23% ± 7% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 21% ± 4% | |
connective tissue cell | 3 studies | 30% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
uterus | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 82% | 4056.56 | 474 / 578 | 65% | 6.49 | 747 / 1155 |
adrenal gland | 65% | 3814.30 | 167 / 258 | 78% | 22.41 | 179 / 230 |
prostate | 63% | 2004.38 | 154 / 245 | 68% | 10.87 | 339 / 502 |
ovary | 85% | 9536.91 | 153 / 180 | 29% | 2.72 | 123 / 430 |
breast | 66% | 1727.79 | 302 / 459 | 45% | 3.73 | 503 / 1118 |
thymus | 60% | 1691.24 | 390 / 653 | 49% | 8.46 | 297 / 605 |
kidney | 42% | 1181.36 | 37 / 89 | 64% | 7.72 | 580 / 901 |
stomach | 47% | 2617.33 | 170 / 359 | 58% | 5.30 | 167 / 286 |
esophagus | 34% | 1226.02 | 491 / 1445 | 68% | 7.46 | 124 / 183 |
eye | 0% | 0 | 0 / 0 | 100% | 40.18 | 80 / 80 |
brain | 27% | 468.41 | 716 / 2642 | 65% | 5.01 | 455 / 705 |
skin | 19% | 277.66 | 338 / 1809 | 72% | 13.51 | 340 / 472 |
intestine | 45% | 1773.23 | 432 / 966 | 46% | 3.88 | 242 / 527 |
bladder | 43% | 829.95 | 9 / 21 | 48% | 4.44 | 240 / 504 |
blood vessel | 86% | 5839.43 | 1143 / 1335 | 0% | 0 | 0 / 0 |
uterus | 42% | 1326.99 | 72 / 170 | 43% | 3.46 | 198 / 459 |
muscle | 83% | 7931.10 | 669 / 803 | 0% | 0 | 0 / 0 |
pancreas | 9% | 119.84 | 31 / 328 | 73% | 9.33 | 130 / 178 |
adipose | 81% | 5163.73 | 974 / 1204 | 0% | 0 | 0 / 0 |
heart | 71% | 6145.87 | 615 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 8.29 | 23 / 45 |
lymph node | 0% | 0 | 0 / 0 | 48% | 2.36 | 14 / 29 |
liver | 19% | 370.49 | 44 / 226 | 22% | 1.23 | 90 / 406 |
peripheral blood | 23% | 333.90 | 214 / 929 | 0% | 0 | 0 / 0 |
spleen | 7% | 126.01 | 18 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071376 | Biological process | cellular response to corticotropin-releasing hormone stimulus |
GO_0097009 | Biological process | energy homeostasis |
GO_0061469 | Biological process | regulation of type B pancreatic cell proliferation |
GO_0010828 | Biological process | positive regulation of glucose transmembrane transport |
GO_2000253 | Biological process | positive regulation of feeding behavior |
GO_0010613 | Biological process | positive regulation of cardiac muscle hypertrophy |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_1904754 | Biological process | positive regulation of vascular associated smooth muscle cell migration |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0031100 | Biological process | animal organ regeneration |
GO_0045333 | Biological process | cellular respiration |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007369 | Biological process | gastrulation |
GO_0048660 | Biological process | regulation of smooth muscle cell proliferation |
GO_0048008 | Biological process | platelet-derived growth factor receptor signaling pathway |
GO_0043303 | Biological process | mast cell degranulation |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0071870 | Biological process | cellular response to catecholamine stimulus |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0044320 | Biological process | cellular response to leptin stimulus |
GO_0032765 | Biological process | positive regulation of mast cell cytokine production |
GO_0038097 | Biological process | positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway |
GO_0035726 | Biological process | common myeloid progenitor cell proliferation |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_1900625 | Biological process | positive regulation of monocyte aggregation |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0045444 | Biological process | fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0035259 | Molecular function | nuclear glucocorticoid receptor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0035497 | Molecular function | cAMP response element binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR4A3 |
Protein name | NR4A3/PIK3R1 fusion protein Nuclear receptor subfamily 4 group A member 3 (Mitogen-induced nuclear orphan receptor) (Neuron-derived orphan receptor 1) (Nuclear hormone receptor NOR-1) |
Synonyms | CSMF CHN fusion MINOR PIK3R1 TEC NOR1 |
Description | FUNCTION: Transcriptional activator that binds to regulatory elements in promoter regions in a cell- and response element (target)-specific manner. Induces gene expression by binding as monomers to the NR4A1 response element (NBRE) 5'-AAAAGGTCA-3' site and as homodimers to the Nur response element (NurRE) site in the promoter of their regulated target genes (By similarity). Plays a role in the regulation of proliferation, survival and differentiation of many different cell types and also in metabolism and inflammation. Mediates proliferation of vascular smooth muscle, myeloid progenitor cell and type B pancreatic cells; promotes mitogen-induced vascular smooth muscle cell proliferation through transactivation of SKP2 promoter by binding a NBRE site (By similarity). Upon PDGF stimulation, stimulates vascular smooth muscle cell proliferation by regulating CCND1 and CCND2 expression. In islets, induces type B pancreatic cell proliferation through up-regulation of genes that activate cell cycle, as well as genes that cause degradation of the CDKN1A (By similarity). Negatively regulates myeloid progenitor cell proliferation by repressing RUNX1 in a NBRE site-independent manner. During inner ear, plays a role as a key mediator of the proliferative growth phase of semicircular canal development (By similarity). Mediates also survival of neuron and smooth muscle cells; mediates CREB-induced neuronal survival, and during hippocampus development, plays a critical role in pyramidal cell survival and axonal guidance. Is required for S phase entry of the cell cycle and survival of smooth muscle cells by inducing CCND1, resulting in RB1 phosphorylation. Binds to NBRE motif in CCND1 promoter, resulting in the activation of the promoter and CCND1 transcription (By similarity). Also plays a role in inflammation; upon TNF stimulation, mediates monocyte adhesion by inducing the expression of VCAM1 and ICAM1 by binding to the NBRE consensus site (By similarity) . In mast cells activated by Fc-epsilon receptor cross-linking, promotes the synthesis and release of cytokines but impairs events leading to degranulation (By similarity). Also plays a role in metabolism; by modulating feeding behavior; and by playing a role in energy balance by inhibiting the glucocorticoid-induced orexigenic neuropeptides AGRP expression, at least in part by forming a complex with activated NR3C1 on the AGRP- glucocorticoid response element (GRE), and thus weakening the DNA binding activity of NR3C1. Upon catecholamines stimulation, regulates gene expression that controls oxidative metabolism in skeletal muscle (By similarity). Plays a role in glucose transport by regulating translocation of the SLC2A4 glucose transporter to the cell surface . Finally, during gastrulation plays a crucial role in the formation of anterior mesoderm by controlling cell migration. Inhibits adipogenesis (By similarity). Also participates in cardiac hypertrophy by activating PARP1 (By similarity). . |
Accessions | ENST00000618101.4 [Q92570-3] A0A1D8GZE0 ENST00000395097.7 [Q92570-1] ENST00000338488.8 [Q92570-2] Q92570 ENST00000330847.1 [Q92570-3] |